Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification

This publication has 100 references indexed in Scilit:

• Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
  JAMA, 2010
• Radiation Resistance of Cancer Stem Cells: The 4 R's of Radiobiology Revisited
  Stem Cells, 2010
• Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer
  Lung Cancer, 2010
• Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
  New England Journal of Medicine, 2009
• Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: Histopathologic features and their prognostic implications
  Lung Cancer, 2009
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
  Nature Medicine, 2008
• Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: A chromogenic in situ hybridization study of 182 patients
  Lung Cancer, 2008
• Epidermal growth factor receptor mutations in lung cancer
  Nature Reviews Cancer, 2007
• Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2005
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004